Kahn Swick & Foti, LLC and KSF partner Charles C. Foti, Jr., former Attorney General of Louisiana, reminded investors with substantial losses that they have until September 22, 2026, to seek lead-plaintiff status in a securities class action against PROCEPT BioRobotics Corporation. The proposed class covers investors who purchased Procept shares from February 28, 2024, through February 25, 2026, inclusive. The case, Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation, No. 26-cv-07691, is pending in the U.S. District Court for the Northern District of California. The complaint alleges that Procept and certain executives failed to disclose material information about U.S. handpiece sales, procedures and inventory. Procept said on February 25, 2026, that handpiece sales had materially exceeded procedures in every quarter since the first quarter of 2023, producing cumulative excess field inventory of more than 10,000 units. U.S. quarterly handpiece sales fell from 13,225 units in the third quarter to 9,400 units, a sequential decline of nearly 30%, and the company widely missed its annual revenue guidance by tens of millions of dollars. Procept shares fell from $27.84 on February 25 to $22.69 on February 27, a decline of more than 18% over two trading days on above-average volume. Investors can contact KSF Managing Partner Lewis Kahn or visit the firm’s case website for information about their rights and potential recovery.